HHS expands PREP Act protections for individuals administering COVID-19 monoclonal antibodies

Sep 10, 2021 - 02:49 PM
COVID19 Web Sized

The Department of Health and Human Services yesterday took action to provide a pathway for all states and territories to increase access to critical COVID-19 monoclonal antibody therapeutics. HHS executed an amendment to the Public Readiness and Emergency Preparedness Act Declaration that expands the pool of professionals now covered under the PREP Act for the administration of COVID-19 monoclonal antibody therapeutics. Specifically, the amendment includes coverage of licensed pharmacists, pharmacy technicians, and pharmacy interns when administering COVID-19 monoclonal antibody therapeutics orally, through intramuscular injection, or through subcutaneous injection. The provision was included as part of President Biden’s COVID-19 action plan released yesterday. For details on other provisions included in the action plan and AHA’s reaction, see yesterday’s Special Bulletin.

Related News Articles

Headline
CMS Administrator Oz and Deputy Administrator Brillman discuss agency’s focus on innovation, reducing waste
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
CDC releases report on flu, COVID-19 vaccination coverage for health care workers for 2024-25 respiratory season 
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
Study estimates more than 155,000 uncounted COVID-19 deaths occurred early during pandemic 
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…